Abstract

Research Article

A Comparative Study of Metoprolol and Amlodipine on Mortality, Disability and Complication in Acute Stroke

Jayantee Kalita*, Dhiraj Kumar, Nagendra B Gutti, Sandeep K Gupta, Anadi Mishra and Vivek Singh

Published: 04 April, 2025 | Volume 9 - Issue 1 | Pages: 039-045

Stress in acute stroke may increase mortality and complications, but there is a paucity of information on the efficacy of beta blockers  over other anti-hypertensive. To report efficacy of metoprolol over amlodipine in reducing mortality, disability and infections in acute stroke. CT/MRI confirmed stroke patients within 3 days of onset were included whose age was 18 to 75 years. Patients with secondary intracerebral hemorrhage, organ failure, pregnancy, malignancy, and immunosuppressant or on beta-blocker/amlodipine were excluded. Stroke risk factors, Glasgow Coma Scale (GCS) score, National Institute of Health Stroke Scale (NIHSS) score and CT/MRI findings were noted. Patients with a blood pressure of > 160/90 mm of Hg were randomized using 1:1 randomization to metoprolol (25 mg on day 1, 50 mg if BP is not controlled) or amlodipine (2.5 mg on day 1, then 5 mg then 10 mg on, subsequent days if BP is not controlled). Other standard treatment was continued. The primary outcome was mortality at 1 month; secondary outcomes included  were in-hospital gastrointestinal hemorrhage, pneumonia, sepsis and 3 months functional outcome based on modified Rankin Scale (mRS). Side effects were noted. 18 (14.4%) patients died; 6 (9.7%) in metoprolol and 12 (19%) in amlodipine (p = 0.20) group. At 3-months, 66 patients had good outcome; 45 (80.4%) in metoprolol and 21 (43.3%) in amlodipine group (p < 0.001). The other secondary outcomes were comparable between the two groups. Metoprolol was withdrawn in 6 patients due to bradycardia, and amlodipine in 5 due to hypotension and in 1 due to allergic reaction. Metoprolol is associated with improved functional outcomes in acute stroke  compared to amlodipine.

Read Full Article HTML DOI: 10.29328/journal.jnnd.1001108 Cite this Article Read Full Article PDF

Keywords:

Intracerebral hemorrhage; Infarction; Beta-blocker; Calcium channel blocker; Outcome

References

  1. GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795-820. Available from: https://doi.org/10.1016/s1474-4422(21)00252-0
  2. Kalita J, Goyal G, Kumar P, Misra UK. Intracerebral hemorrhage in young patients from a tertiary neurology center in North India. J Neurol Sci. 2014;336(1-2):42-7. Available from: https://doi.org/10.1016/j.jns.2013.09.037
  3. Hankey GJ. Population Impact of Potentially Modifiable Risk Factors for Stroke. 2020;51(3):719-728. Available from: https://doi.org/10.1161/strokeaha.119.024154
  4. Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, et al. American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; Council on Functional Genomics and Translational Biology. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. 2014;45(1):315-53. Available from: https://doi.org/10.1161/01.str.0000437068.30550.cf
  5. Algin A, Inan I. The role of radiologic, clinical and biochemical parameters in prediction of stroke mortality. Neurosciences (Riyadh). 2019;24(2):110-114. Available from: https://doi.org/10.17712/nsj.2019.2.20180021
  6. Chen Z, Venkat P, Seyfried D, Chopp M, Yan T, Chen J. Brain-Heart Interaction: Cardiac Complications After Stroke. Circ Res. 2017;121(4):451-468. Available from: https://doi.org/10.1161/circresaha.117.311170
  7. Maier IL, Karch A, Mikolajczyk R, Bähr M, Liman J. Effect of beta-blocker therapy on the risk of infections and death after acute stroke--a historical cohort study. PLoS One. 2015;10(2):e0116836. Available from: https://doi.org/10.1371/journal.pone.0116836
  8. Dorrance AM, Fink G. Effects of Stroke on the Autonomic Nervous System. Compr Physiol. 2015;5(3):1241-63. Available from: https://doi.org/10.1002/cphy.c140016
  9. Zhu H, Wang Z, Yu J, Yang X, He F, Liu Z, et al. Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage. Prog Neurobiol. 2019;178:101610. Available from: https://doi.org/10.1016/j.pneurobio.2019.03.003
  10. Maida CD, Norrito RL, Daidone M, Tuttolomondo A, Pinto A. Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches. Int J Mol Sci. 2020;21(18):6454. Available from: https://doi.org/10.3390/ijms21186454
  11. Prass K, Meisel C, Höflich C, Braun J, Halle E, Wolf T, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198(5):725-36. Available from: https://doi.org/10.1084/jem.20021098
  12. Koton S, Tanne D, Green MS, Bornstein NM. Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004). 2010;34(2):90-6. Available from: https://doi.org/10.1159/000264826
  13. Barer DH, Cruickshank JM, Ebrahim SB, Mitchell JR. Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. Br Med J (Clin Res Ed). 1988;296(6624):737-41. Available from: https://doi.org/10.1136/bmj.296.6624.737
  14. Dziedzic T, Slowik A, Pera J, Szczudlik A. Beta-blockers reduce the risk of early death in ischemic stroke. J Neurol Sci. 2007;252(1):53-6. Available from: https://doi.org/10.1016/j.jns.2006.10.007
  15. Sykora M, Siarnik P, Diedler J; VISTA Acute Collaborators. β-Blockers, Pneumonia, and Outcome After Ischemic Stroke: Evidence From Virtual International Stroke Trials Archive. 2015;46(5):1269-74. Available from: https://doi.org/10.1161/strokeaha.114.008260
  16. Balla HZ, Cao Y, Ström JO. Effect of Beta-Blockers on Stroke Outcome: A Meta-Analysis. Clin Epidemiol. 2021 Mar 16;13:225-236. Available from: https://doi.org/10.2147/clep.s268105
  17. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. 1995;273(2):117-23. Available from: https://pubmed.ncbi.nlm.nih.gov/7799491/
  18. Misra UK, Kalita J, Srivastava M, Mandal SK. A study of prognostic predictors of supratentorial haematomas. J Neurol. 1996;243(1):96-100. Available from: https://doi.org/10.1007/bf00878539
  19. de Margerie-Mellon C, Turc G, Tisserand M, Naggara O, Calvet D, Legrand L, et al. Can DWI-ASPECTS substitute for lesion volume in acute stroke? 2013 Dec;44(12):3565-7. Available from: https://doi.org/10.1161/strokeaha.113.003047
  20. Mandell, Lionel A, and Michael S. Niederman. "Pneumonia." Harrison's Principles of Internal Medicine, 21e. McGraw-Hill Education, 2022. Available from: https://ugc.production.linktr.ee/d40733b1-ae5f-4b54-a04a-59f8dda7e3a8_1-Reduced-Harrison-21st.pdf
  21. Brant EB, Seymour CW, Angus DC. Sepsis and Septic Shock. In: Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson J, editors. Harrison's Principles of Internal Medicine, 21e. McGraw-Hill Education; 2022. Accessed March 06, 2025.
  22. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). 2016;315(8):801-10. Available from: https://doi.org/10.1001/jama.2016.0287
  23. Kalita J, Bastia J, Bhoi SK, Misra UK. Systemic Inflammatory Response Syndrome Predicts Severity of Stroke and Outcome. J Stroke Cerebrovasc Dis. 2015;24(7):1640-8. Available from: https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.03.057
  24. Kalita J, Misra UK, Kumar B. Is β-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage? Neurol Sci. 2013;34(7):1099-104. Available from: https://doi.org/10.1007/s10072-012-1210-y
  25. Potter J, Mistri A, Brodie F, Chernova J, Wilson E, Jagger C, et al. Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial. Health Technol Assess. 2009;13(9):iii, ix-xi, 1-73. Available from: https://doi.org/10.3310/hta13090
  26. Savitz SI, Erhardt JA, Anthony JV, Gupta G, Li X, Barone FC, et al. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab. 2000;20(8):1197-204. Available from: https://doi.org/10.1097/00004647-200008000-00005
  27. Tziomalos K, Giampatzis V, Bouziana SD, Spanou M, Papadopoulou M, Kazantzidou P, et al. Effects of different classes of antihypertensive agents on the outcome of acute ischemic stroke. J Clin Hypertens (Greenwich). 2015;17(4):275-80. Available from: https://doi.org/10.1111/jch.12498
  28. Sundbøll J, Schmidt M, Horváth-Puhó E, Christiansen CF, Pedersen L, Bøtker HE, et al. Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study. BMC Neurol. 2015;15:24. Available from: https://doi.org/10.1186/s12883-015-0279-3
  29. Eizenberg Y, Grossman E, Tanne D, Koton S. Pre-admission treatment with Beta-blockers in hypertensive patients with acute stroke and 3-month outcome-Data from a national stroke registry. J Clin Hypertens (Greenwich). 2018;20(3):568-72. Available from: https://doi.org/10.1111/jch.13211
  30. Yang L, Wenping X, Jinfeng Z, Jiangxia P, Jingbo W, Baojun W. Are beta blockers effective in preventing stroke-associated infections? - a systematic review and meta-analysis. Aging (Albany NY). 2022;14(10):4459-70. Available from: https://doi.org/10.18632/aging.204086
  31. Starr JB, Tirschwell DL, Becker KJ. Increased infections with β-blocker use in ischemic stroke, a β2-receptor mediated process? Neurol Sci. 2017;38(6):967-74. Available from: https://doi.org/10.1007/s10072-017-2877-x
  32. Westendorp WF, Vermeij JD, Brouwer MC, Roos YB, Nederkoorn PJ, van de Beek D; PASS Investigators. Pre-Stroke Use of Beta-Blockers Does Not Lower Post-Stroke Infection Rate: An Exploratory Analysis of the Preventive Antibiotics in Stroke Study. Cerebrovasc Dis. 2016;42(5-6):506-11. Available from: https://doi.org/10.1159/000450926
  33. Maier IL, Becker JC, Leyhe JR, Schnieder M, Behme D, Psychogios MN, et al. Influence of beta-blocker therapy on the risk of infections and death in patients at high risk for stroke induced immunodepression. PLoS One. 2018;13(4):e0196174. Available from: https://doi.org/10.1371/journal.pone.0196174
  34. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318(7200):1730-7. Available from: https://doi.org/10.1136/bmj.318.7200.1730
  35. Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1997;30(1):27-34. Available from: https://doi.org/10.1016/s0735-1097(97)00104-6
  36. Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310(16):1683-91. Available from: https://doi.org/10.1001/jama.2013.278477
  37. van der Jagt M, Miranda DR. Beta-blockers in intensive care medicine: potential benefit in acute brain injury and acute respiratory distress syndrome. Recent Pat Cardiovasc Drug Discov. 2012;7(2):141-51. Available from: https://doi.org/10.2174/157489012801227274
  38. Weir CJ, Bradford AP, Lees KR. The prognostic value of the components of the Glasgow Coma Scale following acute stroke. QJM. 2003;96(1):67-74. Available from: https://doi.org/10.1093/qjmed/hcg008
  39. Das S, Chandra Ghosh K, Malhotra M, Yadav U, Sankar Kundu S, Kumar Gangopadhyay P. Short-term mortality predictors in acute stroke. Ann Neurosci. 2012;19(2):61-7. Available from: https://doi.org/10.5214/ans.0972.7531.12190203
  40. Saunders DE, Clifton AG, Brown MM. Measurement of infarct size using MRI predicts prognosis in middle cerebral artery infarction. Stroke. 1995;26(12):2272-6. Available from: https://doi.org/10.1161/01.str.26.12.2272
  41. Mahdy ME, Ghonimi NA, Elserafy TS, Mahmoud W. The NIHSS score can predict the outcome of patients with primary intracerebral hemorrhage. Egypt J Neurol Psychiatry Neurosurg. 2019;55:21. Available from: https://ejnpn.springeropen.com/articles/10.1186/s41983-019-0056-0
  42. McKeown ME, Prasad A, Kobsa J, Top I, Snider SB, Kidwell C, et al. Midline shift greater than 3 mm independently predicts outcome after ischemic stroke. Neurocrit Care. 2022;36(1):46-51. Available from: https://doi.org/10.1007/s12028-021-01341-x
  43. Yuan MZ, Li F, Fang Q, Wang W, Peng JJ, Qin DY, et al. Research on the cause of death for severe stroke patients. J Clin Nurs. 2018;27(1-2):450-60. Available from: https://doi.org/10.1111/jocn.13954
  44. Chen YC, Chen CM, Liu JL, Chen ST, Cheng ML, Chiu DT. Oxidative markers in spontaneous intracerebral hemorrhage: leukocyte 8-hydroxy-2'-deoxyguanosine as an independent predictor of the 30-day outcome. J Neurosurg. 2011;115(6):1184-90. Available from: https://doi.org/10.3171/2011.7.jns11718
  45. Feibel JH, Hardy PM, Campbell RG, Goldstein MN, Joynt RJ. Prognostic value of the stress response following stroke. JAMA. 1977;238(13):1374-6. Available from: https://pubmed.ncbi.nlm.nih.gov/578192/
  46. Mehta R, Chinthapalli K. Glasgow coma scale explained. BMJ. 2019;365:l1296. Available from: https://doi.org/10.1136/bmj.l1296
  47. McNett M. A review of the predictive ability of Glasgow Coma Scale scores in head-injured patients. J Neurosci Nurs. 2007;39(2):68-75. Available from: https://doi.org/10.1097/01376517-200704000-00002
  48. Hanel RA, Xavier AR, Mohammad Y, Kirmani JF, Yahia AM, Qureshi AI. Outcome following intracerebral hemorrhage and subarachnoid hemorrhage. Neurol Res. 2002;24 Suppl 1:S58-62. Available from: https://doi.org/10.1179/016164102101200041
  49. Kalita J, Mani VE, Bhoi SK, Misra UK. Spectrum and outcome of acute infectious encephalitis/encephalopathy in an intensive care unit from India. QJM. 2017;110(3):141-8. Available from: https://doi.org/10.1093/qjmed/hcw132
  50. Kalita J, Singh RK, Misra UK, Kumar S. Evaluation of cerebral arterial and venous system in tuberculous meningitis. J Neuroradiol. 2018;45(2):130-5. Available from: https://doi.org/10.1016/j.neurad.2017.09.005
  51. Boehme AK, Hays AN, Kicielinski KP, Arora K, Kapoor N, Lyerly MJ, et al. Systemic inflammatory response syndrome and outcomes in intracerebral hemorrhage. Neurocrit Care. 2016;25(1):133-40. Available from: https://doi.org/10.1007/s12028-016-0255-9

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?